Researchers: Yoshiaki Yasutake, Senior Researcher, Applied Molecular Microbiology Research Group, Bioproduction Research Institute The researchers will further generate various modified HIV RT species ...

HIV-1 reverse transcriptase inhibitors have long been central to antiretroviral therapy, effectively impeding the enzyme responsible for converting viral RNA into DNA – a pivotal step in HIV ...

BRANFORD, CT / ACCESSWIRE / August 27, 2024 / A new study demonstrates a significant advancement in our understanding of the template switching mechanism of reverse transcriptases (RTs) that is widely ...

BRANFORD, Conn., August 27, 2024 (Newswire.com) - A new study demonstrates a significant advancement in our understanding of the template switching mechanism of reverse transcriptases (RTs) that is ...

HIV-1 reverse transcriptase inhibitors remain a cornerstone of antiretroviral therapy, targeting the enzyme responsible for converting viral RNA into DNA. This class of drugs, particularly nucleoside ...

BRANFORD, CT / ACCESSWIRE / August 27, 2024 / A new study demonstrates a significant advancement in our understanding of the template switching mechanism of reverse transcriptases (RTs) that is widely ...

Because CRISPR news tends to focus on the applications of genome editing—such as treating genetic diseases or improving food—it may be easy to forget that the system is, at its core, used by bacteria ...

Viral reverse transcriptase (RT) plays a critical role in replication (e.g., retroviruses, that reverse transcribe RNA templates into complementary DNA) and genome mutations (e.g., ...